Once Daily Darunavir/Ritonavir in HIV-infected Children 6-12 Years Old: a Pharmacokinetic Validation of Model Based Dosing Recommendations

Trial Profile

Once Daily Darunavir/Ritonavir in HIV-infected Children 6-12 Years Old: a Pharmacokinetic Validation of Model Based Dosing Recommendations

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Sep 2016

At a glance

  • Drugs Darunavir (Primary) ; Ritonavir (Primary)
  • Indications HIV infections
  • Focus Pharmacokinetics
  • Acronyms DAPHNE
  • Most Recent Events

    • 15 Sep 2016 Status changed from recruiting to completed.
    • 06 Apr 2016 Planned End Date changed from 1 Feb 2016 to 1 Jun 2016 as reported by ClinicalTrials.gov.
    • 06 Apr 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Jun 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top